244 related articles for article (PubMed ID: 12932604)
1. Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease.
Griffiths KA; Sader MA; Skilton MR; Harmer JA; Celermajer DS
J Am Coll Cardiol; 2003 Aug; 42(4):698-704. PubMed ID: 12932604
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
[TBL] [Abstract][Full Text] [Related]
3. Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Koizumi A; Kanai H; Araki Y; Itoh T; Iwasaki T; Sawada Y; Saito Y; Kumakura H; Takayama Y; Kanda T; Murakami M; Sakamaki T; Kurabayashi M
Int Heart J; 2010 Jan; 51(1):60-7. PubMed ID: 20145354
[TBL] [Abstract][Full Text] [Related]
4. Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
Cerquetani E; Vitale C; Mercuro G; Fini M; Zoncu S; Rosano GM
Gynecol Endocrinol; 2004 Jun; 18(6):291-8. PubMed ID: 15497491
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene and endothelial function in healthy postmenopausal women.
Sarrel PM; Nawaz H; Chan W; Fuchs M; Katz DL
Am J Obstet Gynecol; 2003 Feb; 188(2):304-9. PubMed ID: 12592230
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women.
Duschek EJ; Stehouwer CD; de Valk-de Roo GW; Schalkwijk CG; Lambert J; Netelenbos C
J Intern Med; 2003 Jul; 254(1):85-94. PubMed ID: 12823645
[TBL] [Abstract][Full Text] [Related]
7. The effects of raloxifene and simvastatin on plasma lipids and endothelium.
Sbarouni E; Flevari P; Kroupis C; Kyriakides ZS; Koniavitou K; Kremastinos DT
Cardiovasc Drugs Ther; 2003 Jul; 17(4):319-23. PubMed ID: 14618093
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
Johnston CC; Bjarnason NH; Cohen FJ; Shah A; Lindsay R; Mitlak BH; Huster W; Draper MW; Harper KD; Heath H; Gennari C; Christiansen C; Arnaud CD; Delmas PD
Arch Intern Med; 2000 Dec 11-25; 160(22):3444-50. PubMed ID: 11112238
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women.
Cagnacci A; Arangino S; Renzi A; Zanni AL; Volpe A
Am J Obstet Gynecol; 2003 Feb; 188(2):313-7. PubMed ID: 12592232
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene improves the ovariectomy-induced impairment in endothelium-dependent vasodilation.
Takahashi K; Mori-Abe A; Takata K; Ohta T; Kawagoe J; Tsutsumi S; Ohmichi M; Kurachi H
Menopause; 2007; 14(4):656-61. PubMed ID: 17242632
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of raloxifene hydrochloride.
Saitta A; Morabito N; Frisina N; Cucinotte D; Corrado F; D'Anna R; Altavilla D; Squadrito G; Minutoli L; Arcoraci V; Cancellieri F; Squadrito F
Cardiovasc Drug Rev; 2001; 19(1):57-74. PubMed ID: 11314601
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.
Katz DL; Evans MA; Njike VY; Hoxley ML; Nawaz H; Comerford BP; Sarrel PM
Climacteric; 2007 Dec; 10(6):500-7. PubMed ID: 18049943
[TBL] [Abstract][Full Text] [Related]
13. [Effects of raloxifene on endothelial function and hemostasis in women with ischemic heart disease].
Roqué M; Sitges M; Sala J; Delgado V; Morales M; Marrugat J; Vila J; Subirana I; Tàssies D; Reverter JC; Castro M; Duran M
Rev Esp Cardiol; 2011 Jul; 64(7):572-8. PubMed ID: 21601973
[TBL] [Abstract][Full Text] [Related]
14. Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women.
Ceresini G; Marchini L; Rebecchi I; Morganti S; Bertone L; Montanari I; Bacchi-Modena A; Sgarabotto M; Baldini M; Denti L; Ablondi F; Ceda GP; Valenti G
Atherosclerosis; 2003 Mar; 167(1):121-7. PubMed ID: 12618276
[TBL] [Abstract][Full Text] [Related]
15. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
[TBL] [Abstract][Full Text] [Related]
16. The effect of raloxifene on coronary arteries in aged ovariectomized ewes.
Gaynor JS; Monnet E; Selzman C; Parker D; Kaufman L; Bryant HU; Mallinckrodt C; Wrigley R; Whitehill T; Turner AS
J Vet Pharmacol Ther; 2000 Jun; 23(3):175-9. PubMed ID: 11110106
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-independent relaxation to raloxifene in porcine coronary artery.
Leung HS; Seto SW; Kwan YW; Leung FP; Au AL; Yung LM; Yao X; Huang Y
Eur J Pharmacol; 2007 Jan; 555(2-3):178-84. PubMed ID: 17113071
[TBL] [Abstract][Full Text] [Related]
18. Effect of raloxifene on the incidence of elevated low density lipoprotein (LDL) and achievement of LDL target goals in postmenopausal women.
Cox DA; Sarkar S; Harper K; Barrett-Connor E
Curr Med Res Opin; 2004 Jul; 20(7):1049-55. PubMed ID: 15265250
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women.
Blum A; Schenke WH; Hathaway L; Mincemoyer R; Csako G; Waclawiw MA; Cannon RO
Am J Cardiol; 2000 Oct; 86(8):892-5. PubMed ID: 11024411
[No Abstract] [Full Text] [Related]
20. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.
Barrett-Connor E; Grady D; Sashegyi A; Anderson PW; Cox DA; Hoszowski K; Rautaharju P; Harper KD;
JAMA; 2002 Feb; 287(7):847-57. PubMed ID: 11851576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
